Rifampicin (RIF): Gamified Decentralized Science
Rifampicin (RIF) is the gamified compound token for the Rifampicin experiment, representing longevity research conducted with the compound Rifampicin. As part of the decentralized science (DeSci) movement spearheaded by Molecule and BIO Protocol, RIF is connected to the Pump.science platform, which leverages blockchain’s decentralized nature to democratize access to research and innovation.
Key Takeaways:
RIF serves as a cornerstone of Pump.science, a platform gamifying longevity research through blockchain-powered prediction markets.
Users can follow live-streamed Rifampicin experiments, and track the outcomes of longevity studies as they unfold.
RIF represents the synergy between scientific discovery and blockchain funding, empowering communities to engage in longevity research in unprecedented ways.
This guide explores what Pump.science is, the RIF token (including its launch and trading) and the way Pump.science seeks to address critical challenges within longevity research.
The Longevity Trilemma
The problem of the Longevity Trilemma highlights three core challenges in developing life-extending interventions.
Speed: Rapid results are critical, as time is an irreplaceable resource.
Cost: Efficient resource allocation is necessary to explore the vast universe of drug compounds.
Quality: Reliable data must accurately predict human lifespan impacts.
Traditional research, such as that conducted through human and mouse trials, is often slow and expensive. With more potential drug molecules than atoms in the universe, high-throughput methods are essential. Pump.science leverages blockchain and gamification to balance speed, cost and quality, accelerating discoveries while maintaining data integrity.
What Is Pump.science?
Pump.science is a blockchain-based research protocol that democratizes the process of conducting and funding scientific experiments, with a focus on longevity research. By breaking down barriers to scientific innovation, Pump.science fosters a more inclusive and creative environment for discoveries.
The platform allows users to propose longevity-focused drug regimens, test them on experimental platforms such as WormBot (with plans to expand to other models) and retain ownership of the resulting intellectual property (IP). Results are transparently shared for community review and collaboration.
Think of it as a virtual arena for scientific experimentation, in which regimens compete to extend lifespans. The Colosseum is now a petri dish, the gladiators are microscopic organisms and their weapons are cutting-edge longevity strategies.
How Pump.science Aims to Solve the Longevity Trilemma
Gamifying Longevity Research: Pump.science uses tools such as WormBot to gamify research, creating a Percentage Life Extension (PLE) score as a benchmark for success. Here’s how the basic process works:
Submit or Support Regimens: Users propose longevity experiments, creating tokens tied to the regimens. Others can support these regimens by purchasing tokens.
Track Experiments in Real Time: Data from WormBot, including images and growth metrics, is streamed for participants to evaluate.
Trade Tokens: Tokens linked to promising regimens can be traded, creating a prediction market driven by experimental success.
This approach reduces research costs, democratizes participation and introduces a transparent, collaborative system for scientific advancement.
How Pump.science Works
Pump.science is a blockchain-based platform that decentralizes and funds longevity research through gamified experimentation. Its process includes the following steps:
Submit Treatments: Researchers propose interventions for evaluation and testing.
Launch Tokens: Approved interventions are tokenized, with initial tokens sold via a bonding curve to fund early-stage research.
Token Milestones: Experiments progress as token market caps meet specific thresholds:
Worms (C. elegans)
The bonding curve starts at $5K in market cap, similar to pump.fun. When it reaches $10K, a live data stream will start. At a liquidity threshold of 85 SOL, the liquidity will be migrated to Meteora.
Flies
Studies advance at $500K, utilizing AI tools to track movement, survival and compound effects.
Mice
More advanced experiments start at $20M, deepening insights into longevity outcomes.
Humans
The most complex of all experiments, the market cap threshold is $100M.
Track Live Experiments: Users access real-time data, including survival rates, movement analysis and treatment comparisons.
Trade Tokens: Tokens tied to interventions can be traded based on experiment results and performance.
Monetize Results: Token holders retain intellectual property rights, which can be sold to chemical suppliers for broader application.
This milestone-driven approach combines accessible funding with transparent experimentation, enabling a collaborative and efficient path to discovering effective longevity compounds.
Pump.science integrates decentralized funding with structured, milestone-based experimentation, ensuring each stage is financially feasible and tied to measurable thresholds, as follows:
Worm Studies: Initial experiments start with direct funding from token launches. A target market cap of $500K over two weeks is required to generate sufficient fees.
Fly Studies: Experiments with flies are funded through trading fees, with a recommended market cap threshold of $500K for feasibility over two weeks.
Mouse Studies: Larger-scale experiments require a sustained market cap of $20M over two weeks to ensure adequate research funding.
Human Studies: Advanced studies necessitate a market cap of $100M maintained for at least two weeks to align with the financial needs of rigorous experimentation.
These thresholds are informed by extensive analysis of historical trading data on platforms like Solana and Pump.fun, ensuring alignment between funding goals and realistic market behavior.
Efficient and Transparent Research Funding
Submit Treatments: Researchers propose compounds for evaluation and experimentation.
Launch Token: Approved treatments are tokenized with an initial bonding curve and liquidity migration to automated market makers.
Funding via Trading Fees: Of trading fees generated through liquidity pools, 90% are directed toward funding experiments in order to ensure sustainability and scalability.
This structured funding model reduces reliance on centralized gatekeepers, enabling community-driven innovation and collaboration.
What Is Rifampicin (RIF)?
Rifampicin (RIF) is a token on the Solana blockchain that represents ownership in longevity experiments using the compound Rifampicin. Traditionally an antibiotic, Rifampicin is gaining attention for its potential anti-aging properties. Studies of C. elegans (worms) suggest Rifampicin enhances cellular defenses against stress and damage, extending lifespan by maintaining protein quality and reducing oxidative stress.
On Pump.science, investors can fund and monitor real-time experiments by using RIF tokens.
Launch of RIF and Tokenomics
The RIF token represents intellectual property and experimental rights for Rifampicin on Pump.science. Participants can trade the token and view data from studies that assess its impact on longevity. Its tokenomics ensure efficient funding, as well as transparency and scalability for advancing scientific discovery.
Custom Bonding Curve
Each token launch starts with a bonding curve, initially setting the market cap at $5,000 USD.
As liquidity grows, the curve dynamically adjusts prices to reflect demand.
When liquidity reaches 85 SOL, 82 SOL migrates to a Meteora liquidity pool and 3 SOL is used to directly fund initial research.
Liquidity-Driven Research Funding
Trading activity within liquidity pools funds experiments as follows:
90% of fees are allocated to research
10% supports platform operations
Liquidity remains locked, ensuring long-term sustainability while providing funding through fee accrual.
Token Issuance
800M tokens are issued during bonding.
150M tokens and 82 SOL are transferred to the Meteora constant product liquidity pool, while 50M are airdropped pro-rata to holders of previous Pump.science token (RIF and URO at the time of writing).
Market Cap Thresholds
Funding milestones ensure financial feasibility.
Fly Studies: $500K
Mouse Studies: $20M
Human Studies: $100M (average market cap sustained for two weeks).
As trading scales, RIF tokens empower participants to fund and benefit from transformative scientific breakthroughs.
RIF Market Cap and Performance
Rifampicin (RIF) has a fully diluted valuation (FDV) of $42 million, reflecting its total supply of 1 billion tokens. Its price performance indicates its potential, as follows:
All-Time High: $0.2478
All-Time Low: $0.03774
Future Outlook for RIF and Pump.science
Road Map Highlights Pump.science’s clear and ambitious road map for 2025 indicates that the platform is set to expand its impact on decentralized longevity research.
January 2025: Launch of mice experiments utilizing URO and RIF, marking a significant step in advancing compound efficacy research
February 2025: Introduction of new compound launches in collaboration with VitaDAO, strengthening research diversity and partnerships
March 2025: Launch of supplement pre orders alongside a dedicated marketplace, enabling broader community engagement and access to longevity innovations
April 2025: Decentralized human trials begin, alongside the launch of decentralized platforms for compound testing, broadening the scope of real-world applications
May 2025: Expansion into additional experiment types for animals and humans, further solidifying Pump.science as a pioneer in DeSci.
By integrating RIF tokens and leveraging blockchain for funding and data sharing, Pump.science is transforming longevity research into a collaborative and gamified frontier.
Rifampicin (RIF) is now available to trade as a Bybit Perpetual contract. Trade RIF/USDT with up to 25x leverage now!
#LearnWithBybit